Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 103-88-8 | MDL No. : | MFCD00000092 |
Formula : | C8H8BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MSLICLMCQYQNPK-UHFFFAOYSA-N |
M.W : | 214.06 | Pubchem ID : | 7683 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.45 |
TPSA : | 29.1 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 1.91 |
Log Po/w (XLOGP3) : | 2.29 |
Log Po/w (WLOGP) : | 2.22 |
Log Po/w (MLOGP) : | 2.27 |
Log Po/w (SILICOS-IT) : | 2.04 |
Consensus Log Po/w : | 2.15 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.88 |
Solubility : | 0.281 mg/ml ; 0.00131 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.54 |
Solubility : | 0.619 mg/ml ; 0.00289 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.64 |
Solubility : | 0.0486 mg/ml ; 0.000227 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With N-Bromosuccinimide; chloro-trimethyl-silane In acetonitrile at 20℃; for 1 h; | General procedure: To a solution of 4-bromoanisole (200.8 mg, 1.09 mmol, 1.0 equiv) in acetonitrile (2 mL) was added N-chlorosuccinimide(NCS) (158.3 mg, 1.19 mmol, 1.1 equiv) at rt to give a slightly cloudy mixture. Chlorotrimethylsilane (TMSCl) (14 μL, 0.11 mmol, 0.1 equiv) was then added drop-wise to the reaction mixture. Within a few minutes, the reaction mixture became clear pale yellow solution. The mixture continued to stir at rt for 1 h and was diluted with hexane. The biphasic mixture was concentrated on a rotary evaporator to a crude white solid-oil mixture. This mixture was taken up in hexane and filtered through a short plug of SiO2 and eluted with 5-10percent EtOAc-hexane solution. The clear filtrate was concentrated to obtain a mixture of 4-bromo-2-chloro-1-methoxybenzene (2a-Cl) and 2,4-dichloro-1-methoxybenzene (2a-diCl) 237.0 mg (88percent of 2a-Cl and 11percent of 2a-diCl,based on NMR ratio 2a-Cl: 2a-diCl = 7.1: 1.0; as a pale yellow solid). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate; triethylamine In 1,4-dioxane at 20 - 100℃; Inert atmosphere | To a solution of compound 47 (250 mg, 1.45 mmol) in dioxane(6 mL) at room temperature was added bis(pinacolato)diboron(554 g, 2.18 mmol, 1.5 equiv.), and KOAc (427 mg, 4.35 mmol, 3equiv.). The reaction mixture was degassed under N2. Pd(dppf)Cl2(90 mg, 0.12 mmol, 0.1 equiv.) was added to the mixture anddegassed under N2. The reaction mixture was heated to 100 C andstirred overnight under nitrogen. The reaction mixture was monitoredusing TLC until completion, filtered through Celite andwashed with EA. The reaction solvent was evaporated underreduced pressure to give a residue, which was purified via silica gelcolumn chromatography (elution system - EA/Hexane 1: 1) togive compound 48 as a white solid (870 mg, 71percent).Rf 0.43 (EA/Hexane 1: 1); 1H NMR (400 MHz, CDCl3) d 7.76(d, J 8.3 Hz, 2H), 7.51 (d, J 7.9 Hz, 2H), 7.19 (s, 1H), 2.18 (s, 3H),1.33 (s, 12H). |
[ 119430-40-9 ]
N-(3,5-Dibromophenyl)acetamide
Similarity: 0.95
[ 50438-47-6 ]
N-(4-Bromophenyl)-N-methylacetamide
Similarity: 0.92
[ 25462-66-2 ]
N-(2,5-Dibromophenyl)acetamide
Similarity: 0.90
[ 119430-40-9 ]
N-(3,5-Dibromophenyl)acetamide
Similarity: 0.95
[ 50438-47-6 ]
N-(4-Bromophenyl)-N-methylacetamide
Similarity: 0.92
[ 25462-66-2 ]
N-(2,5-Dibromophenyl)acetamide
Similarity: 0.90
[ 119430-40-9 ]
N-(3,5-Dibromophenyl)acetamide
Similarity: 0.95
[ 50438-47-6 ]
N-(4-Bromophenyl)-N-methylacetamide
Similarity: 0.92
[ 25462-66-2 ]
N-(2,5-Dibromophenyl)acetamide
Similarity: 0.90
[ 119430-40-9 ]
N-(3,5-Dibromophenyl)acetamide
Similarity: 0.95
[ 50438-47-6 ]
N-(4-Bromophenyl)-N-methylacetamide
Similarity: 0.92
[ 25462-66-2 ]
N-(2,5-Dibromophenyl)acetamide
Similarity: 0.90